To report secondary efficacy endpoints of Radiation Therapy Oncology Group protocol @ , primary endpoint analysis of which demonstrated that preoperative radiation therapy ( RT ) with capecitabine plus oxaliplatin achieved a pathologic complete remission prespecified threshold ( @ % ) to merit further study , whereas RT with capecitabine plus irinotecan did not ( @ % ) .